AH Lisanti Capital Growth »

Halozyme Therapeutics shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2012-03-31 $3.5M 273k 12.76

More positions owned by AH Lisanti Capital Growth

Five Below (FIVE)
Patterson-UTI Energy (PTEN)
Carpenter Technology Corporation (CRS)
Modine Manufacturing (MOD)
Brightspring Health Svcs (BTSG)
Matador Resources (MTDR)
Knight-swift Transn Hldgs In Cl A (KNX)
Ligand Pharmaceuticals Com New (LGND)
Advanced Energy Industries (AEIS)
Sterling Construction Company (STRL)
Guardian Pharmacy Svcs Cl A (GRDN)
RBC Bearings Incorporated (RBC)
Solaris Energy Infras Com Cl A (SEI)
Fabrinet SHS (FN)
Ensign (ENSG)

View all positions for AH Lisanti Capital Growth

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics